Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

BACKGROUND: Annual MRI screening is associated with a significant reduction in advanced-stage breast cancer diagnosis in BRCA1/2 mutation carriers. The impact that early detection has on subsequent oncological treatment is less frequently reported. In this study we compared disease stage and therape...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast
Autors principals: Bernstein-Molho, Rinat, Kaufman, Bella, Ben David, Merav A., Sklair-Levy, Miri, Feldman, Dana Madoursky, Zippel, Dov, Laitman, Yael, Friedman, Eitan
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7375664/
https://ncbi.nlm.nih.gov/pubmed/31760168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2019.10.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars